Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Other Non-Current Assets (2016 - 2025)

Angiodynamics (ANGO) has disclosed Other Non-Current Assets for 15 consecutive years, with $11.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 9.6% year-over-year to $11.1 million, compared with a TTM value of $11.1 million through Nov 2025, up 9.6%, and an annual FY2025 reading of $10.4 million, down 8.49% over the prior year.
  • Other Non-Current Assets was $11.1 million for Q4 2025 at Angiodynamics, up from $9.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $19.4 million in Q1 2021 and bottomed at $6.2 million in Q2 2023.
  • Average Other Non-Current Assets over 5 years is $11.3 million, with a median of $11.0 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets plummeted 43.87% in 2023, then skyrocketed 84.74% in 2024.
  • Year by year, Other Non-Current Assets stood at $12.1 million in 2021, then fell by 11.53% to $10.7 million in 2022, then plummeted by 42.6% to $6.2 million in 2023, then soared by 64.17% to $10.1 million in 2024, then rose by 9.6% to $11.1 million in 2025.
  • Business Quant data shows Other Non-Current Assets for ANGO at $11.1 million in Q4 2025, $9.5 million in Q3 2025, and $10.4 million in Q2 2025.